Brokerages Set HCA Healthcare, Inc. (NYSE:HCA) PT at $462.64

Shares of HCA Healthcare, Inc. (NYSE:HCA) have received a consensus rating of “Moderate Buy” from the twenty-three ratings firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $462.6364.

HCA has been the subject of several recent research reports. Argus cut their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Truist Financial reduced their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. TD Cowen dropped their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Barclays cut their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Finally, Jefferies Financial Group set a $450.00 price target on HCA Healthcare in a research note on Tuesday, July 14th.

HCA Healthcare Price Performance

Shares of HCA opened at $417.57 on Friday. HCA Healthcare has a one year low of $353.99 and a one year high of $556.52. The firm has a market capitalization of $90.40 billion, a PE ratio of 13.98, a price-to-earnings-growth ratio of 1.45 and a beta of 1.10. The company has a 50-day simple moving average of $401.08 and a two-hundred day simple moving average of $441.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the prior year, the company earned $6.84 earnings per share. The business’s revenue was up 8.7% compared to the same quarter last year. Analysts expect that HCA Healthcare will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is 10.45%.

Hedge Funds Weigh In On HCA Healthcare

Institutional investors have recently added to or reduced their stakes in the company. Sumitomo Life Insurance Co. grew its holdings in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares during the last quarter. MJP Associates Inc. ADV increased its position in HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after acquiring an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC boosted its holdings in HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after purchasing an additional 21 shares during the period. Anchyra Partners LLC increased its holdings in shares of HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after purchasing an additional 21 shares during the period. Finally, Plato Investment Management Ltd grew its position in HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.